For several years, families who believed prenatal acetaminophen exposure contributed to their child’s autism or ADHD watched the federal Tylenol litigation stall. That changed in the summer of 2026. This Tylenol autism lawsuit update explains what the federal appeals court decided, what it did not decide, how the FDA’s 2025 action fits in, and what parents may want to consider now. This Tylenol autism lawsuit update also covers what has happened since the July appeals ruling, key legal terms, and how families can read new headlines with care.
Direct2Attorney is a legal marketing and referral service, not a law firm. We do not give legal or medical advice, and nothing here should be read as a statement that acetaminophen causes autism. That scientific question remains disputed and is exactly what the courts are being asked to sort out.
Tylenol Autism Lawsuit Update: The Short Version
- Federal lawsuits alleging that prenatal acetaminophen use contributed to autism spectrum disorder (ASD) or ADHD were consolidated in 2022 as MDL No. 3043 in the U.S. District Court for the Southern District of New York, before Judge Denise L. Cote.
- In December 2023, the trial court excluded the plaintiffs’ general causation experts under Federal Rule of Evidence 702, which led to the dismissal of the cases.
- On July 13, 2026, the U.S. Court of Appeals for the Second Circuit vacated those rulings, finding the experts’ opinions were admissible, and sent the cases back to the trial court.
- The appeals court said it was not deciding whether acetaminophen actually causes autism or ADHD. That issue goes back to the trial court.
- As of October 2026, the litigation is active again, though further appellate review has been sought and future rulings could change its course.
How the Tylenol Litigation Got Here
Acetaminophen is the active ingredient in Tylenol and many store-brand pain relievers. It has long been considered one of the few pain and fever options available during pregnancy. Beginning around 2022, families filed lawsuits against Johnson & Johnson’s former consumer health business, now Kenvue, and against retailers that sold store-brand acetaminophen. The lawsuits allege the products lacked adequate warnings about possible neurodevelopmental risks from prolonged use during pregnancy. The defendants deny the allegations.
The Judicial Panel on Multidistrict Litigation centralized the federal cases in the Southern District of New York. Like other MDLs, this did not merge the cases into a class action. Each family’s case remains separate, but shared questions, such as whether there is reliable scientific evidence of a link, are decided once for everyone.
The 2023 expert ruling
General causation is the threshold question of whether a substance is capable of causing a condition at all. In December 2023, Judge Cote found the plaintiffs’ experts had not used reliable methods to reach their causation opinions and excluded them. Without admissible general causation testimony, the cases could not move forward, and judgment was entered for the defendants. The plaintiffs appealed.
What the Second Circuit Decided in July 2026
On July 13, 2026, a three-judge panel of the Second Circuit vacated the trial court’s exclusion of the plaintiffs’ experts. The panel concluded that the experts’ opinions were consistent with methods used by other scientists and represented acceptable interpretations of the evidence, meaning disagreements about that evidence are generally for a jury to weigh rather than grounds to exclude the testimony entirely. The court also rejected the argument that federal drug regulations preempted the warning claims.
The appeals court was careful about the limits of its ruling. It said it was not deciding whether there is a general causal relationship between acetaminophen and autism or ADHD. In other words, this Tylenol autism lawsuit update is about whether families get to present their evidence, not about who is right on the science.
What happens next
The cases were returned to the Southern District of New York for further proceedings. Case trackers report that a defendant has asked for rehearing, so the appellate process may not be over. If the ruling stands, the trial court will set schedules for remaining issues, which could include specific causation for individual children, additional expert challenges, and eventually trials or other resolution. Timelines in MDLs are hard to predict and can stretch over years.
Why Rule 702 matters so much
Federal Rule of Evidence 702 sets the standard judges use to decide whether expert testimony is reliable enough for a jury to hear. In drug cases, expert testimony is usually the only way to connect a medication to an injury, so a Rule 702 ruling can decide whether thousands of cases move forward or end. Rule 702 was amended in December 2023 to emphasize that the party offering an expert must show the testimony is more likely than not reliable. The Second Circuit’s decision is significant because it addressed how strictly judges should screen scientific disagreements before trial.
For families who are following each Tylenol autism lawsuit update, it may help to remember that MDL timelines are measured in months and years, not weeks. Staying organized, keeping records in one place, and checking in with a participating attorney periodically is usually more productive than reacting to every headline.
The FDA’s September 2025 Action on Acetaminophen in Pregnancy
On September 22, 2025, the U.S. Food and Drug Administration announced that it was initiating a safety label change for acetaminophen and sent a notice to physicians about a possible association between acetaminophen use during pregnancy and neurological conditions such as autism and ADHD in children.
The FDA’s announcement also included important caveats. It stated that a causal relationship has not been established and that there are contrary studies in the scientific literature. It also noted that acetaminophen is the only over-the-counter drug approved to treat fever during pregnancy, that high fevers can themselves pose risks, and that it remains reasonable to use acetaminophen in certain situations. Pregnant patients should talk with their clinician before changing how they treat pain or fever.
For the litigation, the FDA’s action is part of the broader background, but courts decide admissibility and causation based on the evidence presented in each case.
Who Is Looking Into a Tylenol Autism Lawsuit?
Participating law firms reviewing these claims typically ask about:
- Prenatal exposure: whether the birth mother used acetaminophen during pregnancy, and roughly how often and for how long.
- The product: brand-name Tylenol or a store brand, and where it was purchased, if known.
- The diagnosis: a formal diagnosis of autism spectrum disorder or ADHD from a qualified clinician.
- Timing: the child’s date of birth and date of diagnosis, which can affect filing deadlines.
- Other factors: family history and other medical facts that a firm may consider when evaluating a case.
Every case is different, and a participating law firm decides whether it can take a particular claim.
Records That Can Help
Over-the-counter medication use is often not written down, which is one of the challenges in these cases. Records that may help include:
- Prenatal care records, where a provider may have noted acetaminophen use for headaches, fever, or pain
- Hospital records from pregnancy or delivery mentioning medications
- Pharmacy or store loyalty-card purchase histories, if available
- Your child’s developmental evaluations and diagnostic reports
- School evaluations, therapy records, or individualized education program (IEP) documents
- A written timeline of the pregnancy, medication use, and when developmental concerns appeared
It is normal not to have every record. Writing down what you remember now, while details are fresh, can be useful. For a look at how another multidistrict case has been organized and explained, see our post on how MDL 3140 and an FDA warning shaped the Depo-Provera litigation.
Deadlines After the Appeals Ruling
Statutes of limitations for injury claims vary by state, and claims involving children often follow special rules that may pause, or “toll,” the deadline until the child reaches adulthood. However, not every claim is tolled in every state, and a parent’s own claims may have different deadlines than the child’s. Because the 2026 ruling may lead some families to revisit the issue, it is worth having a participating attorney licensed in your state review timing questions promptly.
Questions to Ask a Participating Law Firm
If a participating law firm reviews your family’s situation, it is reasonable to ask questions of your own:
- How does the July 2026 appeals ruling affect a case like ours?
- What records do you need from us, and can you help request them?
- What deadlines might apply to my child’s claim and to any claims of my own?
- How are fees and case costs handled if there is no recovery?
- How will you keep us updated as the MDL moves forward?
A good firm will answer plainly and will not promise a particular result.
What a Free Case Review Involves
When you contact Direct2Attorney, an intake specialist asks basic questions about the pregnancy, acetaminophen use, your child’s diagnosis, and key dates. If your situation appears to fit what a participating law firm is reviewing, we connect you with that firm at no cost. The review is confidential.
The participating law firm decides whether to take the case. There are no guarantees that a firm will accept a claim or that any compensation will be recovered. Before signing any agreement, read it carefully and ask how fees and costs work.
Tylenol Autism Lawsuit Update: What Has Happened Since July
The Second Circuit’s July 13, 2026 decision was a major turning point, but it was not the final word. Here is what has been publicly reported since then, and what may come next.
The rehearing request
According to Lowenstein Sandler, several defendants asked the Second Circuit on September 10, 2026 to reconsider its decision. They argued the ruling undercut the 2023 amendment to Rule 702. As of that report, the court had not ruled on the request.
What the appeals court actually decided
The appeals court reversed the exclusion of three of the plaintiffs’ five general causation witnesses. It did not decide whether acetaminophen causes autism or ADHD. It decided that those three witnesses’ opinions should not have been kept out under the evidence rules.
Who is on the other side
The defendants include Kenvue, which makes Tylenol, along with pharmacy and retail chains that sold store-brand acetaminophen. OpenClassActions reported that Kenvue has said it will challenge the reliability of the plaintiffs’ scientific evidence again once the cases return to the district court.
What could come next
- The Second Circuit could grant or deny the rehearing request.
- If the decision stands, the cases would return to the district court in New York.
- Defendants may again challenge the plaintiffs’ scientific evidence there.
- The court could later set schedules for discovery or test trials.
Each of these steps can take months. Families who already have claims on file usually do not need to do anything new right now, but they should keep their contact details current with their law firm. Any Tylenol autism lawsuit update you read should be checked against which stage the case is actually in.
Legal Terms You Will See in Tylenol Updates
Court news about these cases often uses unfamiliar words. These plain-language definitions can help.
- MDL (multidistrict litigation): A way of grouping similar federal cases before one judge for pretrial steps. The federal acetaminophen cases are in MDL No. 3043.
- Rule 702: The federal evidence rule for opinions from scientific and other specialized witnesses. The text of Rule 702 says the side offering such a witness must show it is more likely than not that the testimony meets the rule’s reliability requirements.
- General causation: Whether a substance can cause a condition in people in general.
- Specific causation: Whether the substance caused the condition in a particular child.
- Vacate or reverse: When a higher court sets aside a lower court’s ruling.
- Rehearing: A request asking an appeals court to look at its own decision again.
- Bellwether trial: An early test trial used to show how juries may respond to similar cases.
Knowing these terms makes it easier to tell whether a Tylenol autism lawsuit update describes a big change or a small procedural step.
How to Read a Tylenol Autism Lawsuit Update Without Being Misled
Headlines can make court news sound more final than it is. Ads may also use urgent language. A few simple habits can help you separate facts from hype.
- Look for the court and the date. A reliable update names the court that acted and when.
- Check whether it is a ruling or a request. A request for rehearing is not the same as a decision.
- Watch for promises. Be cautious of anyone who promises a payout or says a settlement is certain. No settlement has been publicly announced in the federal cases.
- Notice who is talking. Law firms, drug companies and advocacy groups each have a point of view.
- Go to the source when you can. Court orders and official agency pages, such as FDA notices, are the most reliable.
If something in a Tylenol autism lawsuit update seems confusing, a participating law firm can explain what it means for families in your situation.
Caring for Your Family While the Case Continues
Legal news can stir up guilt or worry, especially for parents who took acetaminophen during pregnancy. Many parents took it on a doctor’s advice to treat fever or pain. Whatever happens in court, your child’s care and your own well-being matter most.
Focus on support that helps now
- Keep up with your child’s therapies, school supports and medical care.
- Ask your child’s care team about local resources and support groups.
- Take care of your own stress and sleep, and reach out to friends or a counselor.
Talking with your partner and family
Parents sometimes disagree about whether to look into a claim, and that is normal. It can help to read the same Tylenol autism lawsuit update together, write down your questions and decide on next steps as a team. Grandparents and other relatives may have opinions too, but the choice belongs to the child’s parents or guardians.
Keep records in one place
Store pregnancy records, pharmacy receipts, your child’s diagnosis records and evaluation reports in one folder. Even if you are not ready to decide, organized records make any future case review easier.
Talk with your doctor about current medicine questions
If you are pregnant now and have questions about pain or fever medicine, talk with your doctor before stopping or starting anything. Do not let a Tylenol autism lawsuit update replace medical advice from someone who knows your health history.
Deadlines can still apply while appeals continue, and they vary by state. If you are considering a claim, staying informed through each Tylenol autism lawsuit update and speaking with a firm early can help protect your options.
Tylenol Autism Lawsuit Update FAQ
Did the court rule that Tylenol causes autism?
No. The Second Circuit specifically said it was not deciding whether acetaminophen causes autism or ADHD. It ruled that the plaintiffs’ expert testimony should not have been excluded.
Is there a Tylenol autism settlement?
As of October 2026, no settlement of the federal litigation has been announced. Be cautious about any site quoting specific payout amounts.
Who are the defendants?
The federal cases name Kenvue, the company that makes Tylenol, along with retailers that sold store-brand acetaminophen.
Can I still file if my earlier case was dismissed?
That depends on the status of your earlier case and how the appeals ruling applies to it. A participating attorney can review your specific history.
Should I avoid acetaminophen during pregnancy?
That is a medical decision. The FDA has said a causal link has not been established and that acetaminophen use remains reasonable in certain situations. Talk with your doctor or midwife.
Does Direct2Attorney represent families?
No. Direct2Attorney is not a law firm. We connect families with participating law firms, and those firms decide whether to take a case.
Key Takeaways
The most important Tylenol autism lawsuit update of 2026 is that the federal cases are back in play after the Second Circuit’s July ruling. The science is still contested, further appeals are possible, and each case will depend on its own facts. If you are a parent with questions, gathering records and getting a free, confidential review can help you understand your options.
Think you may qualify? See if you qualify for a free, confidential Tylenol Autism case review →
This article is general information, not legal or medical advice. Direct2Attorney is not a law firm. Contacting us does not create an attorney-client relationship, and no outcome or compensation is guaranteed.
